Literature DB >> 23327602

Signaling pathways of prohibitin and its role in diseases.

Tian-Biao Zhou1, Yuan-Han Qin.   

Abstract

Prohibitin (PHB), appearing to be a negative regulator of cell proliferation and to be a tumor suppressor, has been connected to diverse cellular functions including cell cycle control, senescence, apoptosis and the regulation of mitochondrial activities. It is a growth regulatory gene that has pleiotropic functions in the nucleus, mitochondria and cytoplasmic compartments. However, in different tissues/cells, the expression of PHB was different, such as that it was increased in most of the cancers, but its expression was reduced in kidney diseases. Signaling pathways might be very important in the pathogenesis of diseases. This review was performed to provide a relatively complete signaling pathways flowchart for PHB to the investigators who were interested in the roles of PHB in the pathogenesis of diseases. Here, we review the signal transduction pathways of PHB and its role in the pathogenesis of diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23327602     DOI: 10.3109/10799893.2012.752006

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  24 in total

1.  Characterization of mitochondrial prohibitin from Boleophthalmus pectinirostris and evaluation of its possible role in spermatogenesis.

Authors:  Di Wang; Yong-Qiang Zhao; Ying-Li Han; Cong-Cong Hou; Jun-Quan Zhu
Journal:  Fish Physiol Biochem       Date:  2017-05-13       Impact factor: 2.794

2.  Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.

Authors:  Maria Rita Milone; Biagio Pucci; Tommaso Colangelo; Rita Lombardi; Federica Iannelli; Vittorio Colantuoni; Lina Sabatino; Alfredo Budillon
Journal:  Mol Oncol       Date:  2016-07-25       Impact factor: 6.603

3.  Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.

Authors:  Ning Zhong; Yazhou Cui; Xiaoyan Zhou; Tianliang Li; Jinxiang Han
Journal:  Tumour Biol       Date:  2014-10-25

4.  Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.

Authors:  N A Doudican; S J Orlow
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

5.  Adriamycin resistance-associated prohibitin gene inhibits proliferation of human osteosarcoma MG63 cells by interacting with oncogenes and tumor suppressor genes.

Authors:  Min-Dong Du; Kai-Yi He; Gang Qin; Jin Chen; Jin-Yi Li
Journal:  Oncol Lett       Date:  2016-07-14       Impact factor: 2.967

Review 6.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

7.  Quantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model.

Authors:  Sophie Rogée; Morgane Le Gall; Philippe Chafey; Jérôme Bouquet; Nathalie Cordonnier; Christian Frederici; Nicole Pavio
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

8.  Studies on the antiviral activity of chebulinic acid against dengue and chikungunya viruses and in silico investigation of its mechanism of inhibition.

Authors:  Naiju Thomas; Poonam Patil; Anjana Sharma; Sandeep Kumar; Vikas Kumar Singh; Kalichamy Alagarasu; Deepti Parashar; Suman Tapryal
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

9.  Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Feng-Ying Lei; Wei-Fang Huang; Gregor P C Drummen
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

10.  Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.

Authors:  Monica Parodi; Marco Pedrazzi; Claudia Cantoni; Monica Averna; Mauro Patrone; Maria Cavaletto; Stefano Spertino; Daniela Pende; Mirna Balsamo; Gabriella Pietra; Simona Sivori; Simona Carlomagno; Maria Cristina Mingari; Lorenzo Moretta; Bianca Sparatore; Massimo Vitale
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.